Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine M V Moore

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|March 23, 2016
A new chapter in pharmaceutical manufacturing: 3D-printed drug productsJames Norman, Rapti D Madurawe, Christine M V Moore, et al.
AAPS Pharmscitech|July 16, 2016
A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed ProcessBhaveshkumar H Kothari, Raafat Fahmy, H Gregg Claycamp, et al.
Plos One|February 6, 2014
Chemometric analysis for identification of botanical raw materials for pharmaceutical use: a case study using Panax notoginsengJieqiang Zhu, Xiaohui Fan, Yiyu Cheng, et al.
AAPS Pharmscitech|October 4, 2018
Comparing a Statistical Model and Bayesian Approach to Establish the Design Space for the Coating of Ciprofloxacin HCl Beads at Different Scales of ProductionBhaveshkumar H Kothari, Raafat Fahmy, H Gregg Claycamp, et al.
Journal of Pharmaceutical Sciences|September 3, 2021
Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient AccessMarquerita Algorri, Michael J Abernathy, Nina S Cauchon, et al.
Journal of Pharmaceutical Sciences|January 27, 2024
Patient-Centric Quality StandardsAnthony Mire-Sluis, John Dobbins, Christine M V Moore, et al.
Analytical Chemistry|January 4, 2011
Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniquesQingda Zang, David A Keire, Richard D Wood, et al.
Analytical and Bioanalytical Chemistry|October 19, 2010
Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectraQingda Zang, David A Keire, Richard D Wood, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 11, 2011
Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminantsQingda Zang, David A Keire, Richard D Wood, et al.
Analytical and Bioanalytical Chemistry|June 17, 2011
Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral dataQingda Zang, David A Keire, Lucinda F Buhse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|March 23, 2016
A new chapter in pharmaceutical manufacturing: 3D-printed drug productsJames Norman, Rapti D Madurawe, Christine M V Moore, et al.
AAPS Pharmscitech|July 16, 2016
A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed ProcessBhaveshkumar H Kothari, Raafat Fahmy, H Gregg Claycamp, et al.
Plos One|February 6, 2014
Chemometric analysis for identification of botanical raw materials for pharmaceutical use: a case study using Panax notoginsengJieqiang Zhu, Xiaohui Fan, Yiyu Cheng, et al.
AAPS Pharmscitech|October 4, 2018
Comparing a Statistical Model and Bayesian Approach to Establish the Design Space for the Coating of Ciprofloxacin HCl Beads at Different Scales of ProductionBhaveshkumar H Kothari, Raafat Fahmy, H Gregg Claycamp, et al.
Journal of Pharmaceutical Sciences|September 3, 2021
Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient AccessMarquerita Algorri, Michael J Abernathy, Nina S Cauchon, et al.
Journal of Pharmaceutical Sciences|January 27, 2024
Patient-Centric Quality StandardsAnthony Mire-Sluis, John Dobbins, Christine M V Moore, et al.
Analytical Chemistry|January 4, 2011
Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniquesQingda Zang, David A Keire, Richard D Wood, et al.
Analytical and Bioanalytical Chemistry|October 19, 2010
Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectraQingda Zang, David A Keire, Richard D Wood, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 11, 2011
Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminantsQingda Zang, David A Keire, Richard D Wood, et al.
Analytical and Bioanalytical Chemistry|June 17, 2011
Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral dataQingda Zang, David A Keire, Lucinda F Buhse, et al.
Pageof 2